Diversified Investment Strategies LLC Raises Holdings in Nutrien Ltd. (NYSE:NTR)

Diversified Investment Strategies LLC lifted its stake in Nutrien Ltd. (NYSE:NTR) by 0.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 93,902 shares of the company’s stock after acquiring an additional 750 shares during the period. Nutrien comprises about 2.7% of Diversified Investment Strategies LLC’s holdings, making the stock its 14th biggest position. Diversified Investment Strategies LLC’s holdings in Nutrien were worth $4,202,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of NTR. Silchester International Investors LLP lifted its holdings in shares of Nutrien by 164.4% in the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock valued at $513,437,000 after buying an additional 6,642,075 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Nutrien during the 3rd quarter valued at about $150,181,000. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock valued at $121,271,000 after buying an additional 1,100,000 shares in the last quarter. Toronto Dominion Bank increased its holdings in Nutrien by 11.9% in the 3rd quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock worth $202,830,000 after acquiring an additional 447,413 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Nutrien by 34.2% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,287,220 shares of the company’s stock worth $61,848,000 after purchasing an additional 327,799 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Stock Up 0.2 %

NYSE:NTR opened at $52.56 on Wednesday. Nutrien Ltd. has a 52 week low of $43.69 and a 52 week high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock’s fifty day moving average is $47.88 and its two-hundred day moving average is $48.02. The stock has a market capitalization of $25.81 billion, a price-to-earnings ratio of 35.29, a price-to-earnings-growth ratio of 1.17 and a beta of 0.81.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). The firm had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The business’s revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.35 earnings per share. Research analysts anticipate that Nutrien Ltd. will post 3.5 EPS for the current year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st were given a $0.939 dividend. This represents a $3.76 annualized dividend and a yield of 7.15%. The ex-dividend date was Tuesday, December 31st. This is a boost from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s dividend payout ratio (DPR) is currently 144.97%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on NTR shares. Wells Fargo & Company increased their price objective on Nutrien from $52.00 to $53.00 and gave the company an “equal weight” rating in a research note on Tuesday. TD Securities lowered their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research report on Tuesday, November 12th. Raymond James raised shares of Nutrien from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $58.00 to $60.00 in a research note on Tuesday, December 3rd. Oppenheimer assumed coverage on Nutrien in a research report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price target for the company. Finally, Piper Sandler lifted their price objective on Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, Nutrien presently has an average rating of “Moderate Buy” and a consensus target price of $58.94.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.